Literature DB >> 1638274

Neural changes in acute arthritis in monkeys. IV. Time-course of amino acid release into the lumbar dorsal horn.

L S Sorkin1, K N Westlund, K A Sluka, P M Dougherty, W D Willis.   

Abstract

Extracellular levels of amino acids were measured during the development of experimental arthritis in anesthetized monkeys. Levels of glutamate, aspartate, glycine, serine, glutamine, taurine, cysteic acid and asparagine were each measured in consecutive 30 min samples before, during and for several hours after injection of kaolin and carrageenan into the articular capsule of one knee. Samples were obtained via a microdialysis probe placed in the lumbar dorsal horn ipsilateral to the injected knee and assayed using HPLC with fluorescence detection. Glutamate, aspartate, glycine and serine increased transiently following intra-articular injection of inflammatory agents. During this period glutamine levels decreased. A second phase of release then occurred which included more prolonged changes in amino acid levels that were sometimes of greater magnitude than those immediately following the injection. In animals which were later observed to have depletion of SP in the dorsal horn of the inflamed side, taurine levels increased starting after the Glu, Asp and Gly had plateaued at near baseline concentrations. Thus during the first stages of joint inflammation EAAs are released into the dorsal horn, followed by increased levels of IAAs, possibly representing activation of the descending endogenous analgesia system. This phase is followed by a semiacute response consisting in part of increased extracellular levels of SP and Tau. While SP is presumably part of an ascending nociceptive transmission system, Tau could be part of a second system aimed at reducing excessive neural activity including neural transmission resulting in intense maintained pain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1638274     DOI: 10.1016/0165-0173(92)90005-7

Source DB:  PubMed          Journal:  Brain Res Brain Res Rev


  20 in total

1.  Chapter 9 The dorsal horn and hyperalgesia.

Authors:  Karin N Westlund
Journal:  Handb Clin Neurol       Date:  2006

2.  Enhanced phosphorylation of NMDA receptor 1 subunits in spinal cord dorsal horn and spinothalamic tract neurons after intradermal injection of capsaicin in rats.

Authors:  X Zou; Q Lin; W D Willis
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

3.  Neurophysiology of Cancer Pain: From the Laboratory to the Clinic.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

Review 4.  Preemptive analgesia: the prevention of neurogenous orofacial pain.

Authors:  P A Foreman
Journal:  Anesth Prog       Date:  1995

5.  Involvement of cGMP in nociceptive processing by and sensitization of spinothalamic neurons in primates.

Authors:  Q Lin; Y B Peng; J Wu; W D Willis
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

6.  Central Control of Peripheral Joint Inflammation and Heat Hyperalgesia.

Authors:  Kathleen A Sluka; William D Willis; Karin N Westlund
Journal:  Prog Pain Res Manag       Date:  1994-01-01

Review 7.  Combination therapy for neuropathic pain: a review of current evidence.

Authors:  Yakov Vorobeychik; Vitaly Gordin; Jianren Mao; Lucy Chen
Journal:  CNS Drugs       Date:  2011-12-01       Impact factor: 5.749

8.  A peripheral neuroimmune link: glutamate agonists upregulate NMDA NR1 receptor mRNA and protein, vimentin, TNF-alpha, and RANTES in cultured human synoviocytes.

Authors:  Terry A McNearney; Yinghong Ma; Yueping Chen; Giulio Taglialatela; Huaizhi Yin; Wen-Ru Zhang; Karin N Westlund
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-09       Impact factor: 3.619

Review 9.  The role of TRPV1 receptors in pain evoked by noxious thermal and chemical stimuli.

Authors:  William D Willis
Journal:  Exp Brain Res       Date:  2009-03-18       Impact factor: 1.972

Review 10.  Translational pain research: achievements and challenges.

Authors:  Jianren Mao
Journal:  J Pain       Date:  2009-07-22       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.